关注
Weston Whitaker
Weston Whitaker
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Gut microbiota-produced tryptamine activates an epithelial G-protein-coupled receptor to increase colonic secretion
Y Bhattarai, BB Williams, EJ Battaglioli, WR Whitaker, L Till, M Grover, ...
Cell host & microbe 23 (6), 775-785. e5, 2018
3502018
An exclusive metabolic niche enables strain engraftment in the gut microbiota
ES Shepherd, WC DeLoache, KM Pruss, WR Whitaker, JL Sonnenburg
Nature 557 (7705), 434-438, 2018
3172018
Tunable expression tools enable single-cell strain distinction in the gut microbiome
WR Whitaker, ES Shepherd, JL Sonnenburg
Cell 169 (3), 538-546. e12, 2017
2062017
Toward scalable parts families for predictable design of biological circuits
JB Lucks, L Qi, WR Whitaker, AP Arkin
Current opinion in microbiology 11 (6), 567-573, 2008
1532008
Engineering robust control of two-component system phosphotransfer using modular scaffolds
WR Whitaker, SA Davis, AP Arkin, JE Dueber
Proceedings of the National Academy of Sciences 109 (44), 18090-18095, 2012
1062012
Design and implementation of a biomolecular concentration tracker
V Hsiao, ELC De Los Santos, WR Whitaker, JE Dueber, RM Murray
ACS synthetic biology 4 (2), 150-161, 2015
992015
Metabolic pathway flux enhancement by synthetic protein scaffolding
WR Whitaker, JE Dueber
Methods in enzymology 497, 447-468, 2011
462011
Avoidance of truncated proteins from unintended ribosome binding sites within heterologous protein coding sequences
WR Whitaker, H Lee, AP Arkin, JE Dueber
ACS synthetic biology 4 (3), 249-257, 2015
452015
Engineering Modular Post-Translational Control Strategies in Prokaryotes
WR Whitaker
University of California, Berkeley, 2012
32012
Design and implementation of a synthetic biomolecular concentration tracker
V Hsiao, ELC de los Santos, WR Whitaker, JE Dueber, RM Murray
bioRxiv, 000448, 2013
22013
Methods and compositions for treating hyperoxaluria
ZN Russ IV, WR Whitaker, WC DeLoache, EJS Shepherd
US Patent App. 17/312,166, 2022
12022
Biologically contained bacteria and uses thereof
WR Whitaker, WC DeLoache, ZN Russ IV, EJS Shepherd, L Popov
US Patent App. 17/618,130, 2024
2024
Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell
JL Sonnenburg, WR Whitaker, E Stanley, WC DeLoache
US Patent App. 18/391,513, 2024
2024
Compositions and methods for modulating growth of a genetically modified gut bacterial cell
JL Sonnenburg, WR Whitaker, E Stanley, WC DeLoache
US Patent App. 18/501,768, 2024
2024
Compositions and methods for nucleic acid expression and protein secretion in bacteroides
JL Sonnenburg, WR Whitaker, E Stanley
US Patent App. 18/447,700, 2024
2024
Compositions and methods for nucleic acid expression and protein secretion in Bacteroides
JL Sonnenburg, WR Whitaker, E Stanley
US Patent 11,766,461, 2023
2023
Compositions and methods for modulating growth of a genetically modified gut bacterial cell
JL Sonnenburg, WR Whitaker, E Stanley, WC DeLoache
US Patent 11,566,238, 2023
2023
Compositions and Methods for Modulating Growth of a Genetically Modified Gut Bacterial Cell
JL Sonnenburg, WR Whitaker, E Stanley, WC DeLoache
US Patent App. 17/675,721, 2022
2022
Compositions and methods for modulating growth of a genetically modified gut bacterial cell
JL Sonnenburg, WR Whitaker, E Stanley, WC DeLoache
US Patent 11,254,918, 2022
2022
Compositions and methods for modulating growth of a genetically modified gut bacterial cell
JL Sonnenburg, WR Whitaker, E Stanley, WC DeLoache
US Patent App. 16/047,862, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20